Reference data : LOINC code

Filter


Clear filter

Results
101,632 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK COMMON_SI_TEST_RANK
100041-3 Aminoglycoside Susc Isolate Pt OrdQn     ACTIVE Aminoglycoside [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100041-3         Both       0 Aminoglycoside Susc Islt       N   Amikacin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c288; Gentamicin; Islt; Isol; Neomycin; Point in time; Random; Streptomycin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tobramycin 2.72 2.72                       0  
100042-1 Atovaquone Susc Isolate Pt OrdQn     ACTIVE Atovaquone [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100042-1         Both       0 Atovaquone Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Atavaquone; Islt; Isol; Mepron; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100043-9 Azithromycin+Ethambutol Susc Isolate Pt OrdQn     ACTIVE Azithromycin+Ethambutol [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100043-9         Both       0 Azithro+Ethambut Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Azithro+Ethambut; Etambol; Ethamb; Inagen; Islt; Isol; Myambutol; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zithromax 2.72 2.72                       0  
100044-7 Cefcapene Susc Isolate Pt OrdQn     ACTIVE Cefcapene [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100044-7         Both       0 Cefcapene Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100045-4 Cefozopran Susc Isolate Pt OrdQn     ACTIVE Cefozopran [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100045-4         Both       0 Cefozopran Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100046-2 Cefquinome Susc Isolate Pt OrdQn     ACTIVE Cefquinome [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100046-2         Both       0 CEQ Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; CEQ; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100047-0 Cefteram Susc Isolate Pt OrdQn     ACTIVE Cefteram [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100047-0         Both       0 Cefteram Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefterame; Cefteramum; Ceftetrame; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100048-8 Clarithromycin+Ethambutol Susc Isolate Pt OrdQn     ACTIVE Clarithromycin+Ethambutol [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100048-8         Both       0 Clarithro+Ethamb Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; Clarithro+Ethamb; Etambol; Ethamb; Inagen; Islt; Isol; Klacid; Myambutol; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100049-6 Eravacycline Susc Isolate Pt OrdQn     ACTIVE Eravacycline [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100049-6         Both       0 Eravacycline Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
10005-7 R wave duration.lead V2 Time Heart Pt Qn EKG   ACTIVE R wave duration in lead V2   MIN DefinitionDescription     s             EKG.MEAS   10005-7   EKG     Observation       0 R wave dur L-V2       Y   Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-V2; R wave dur L-V2; Random; Right 2.48 1.0i               s       0  
100050-4 Erythromycin+Ethambutol Susc Isolate Pt OrdQn     ACTIVE Erythromycin+Ethambutol [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100050-4         Both       0 Erythro+Ethamb Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; c212; EES; Erygel; Erythro+Ethamb; Erythromycn; Etambol; Ethamb; Ilosone; Ilotycin; Iltycin; Inagen; Islt; Isol; Myambutol; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100051-2 Ethambutol+rifAMPin Susc Isolate Pt OrdQn     ACTIVE Ethambutol+rifAMPin [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100051-2         Both       0 Ethambutol+rifAMPin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; Etambol; Ethamb; Inagen; Islt; Isol; Myambutol; Mycobutol; Olbutam; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100052-0 Flomoxef Susc Isolate Pt OrdQn     ACTIVE Flomoxef [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100052-0         Both       0 Flomoxef Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Flomoxefum; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100053-8 Fluoroquinolone Susc Isolate Pt OrdQn     ACTIVE Fluoroquinolone [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100053-8         Both       0 FLQ Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; FLQ; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100054-6 Gamithromycin Susc Isolate Pt OrdQn     ACTIVE Gamithromycin [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100054-6         Both       0 Gamithromycin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Bovine Respiratory Disease; BRD; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Zactran 2.72 2.72                       0  
100055-3 Optochin Susc Isolate Pt OrdQn     ACTIVE Optochin [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100055-3         Both       0 Optochin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100056-1 Panipenem Susc Isolate Pt OrdQn     ACTIVE Panipenem [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100056-1         Both       0 Panipenem Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Panipenum; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100057-9 Prothionamide Susc Isolate Pt OrdQn     ACTIVE Prothionamide [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100057-9         Both       0 Prothionamide Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Protionamide; PTH; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100058-7 Prulifloxacin Susc Isolate Pt OrdQn     ACTIVE Prulifloxacin [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100058-7         Both       0 Prulifloxacin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Pruquin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100059-5 Rifapentine Susc Isolate Pt OrdQn     ACTIVE Rifapentine [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100059-5         Both       0 Rifapentine Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
10006-5 R wave duration.lead V3 Time Heart Pt Qn EKG   ACTIVE R wave duration in lead V3   MIN DefinitionDescription     s             EKG.MEAS   10006-5   EKG     Observation       0 R wave dur L-V3       Y   Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-V3; R wave dur L-V3; Random; Right 2.48 1.0i               s       0  
100060-3 Tildipirosin Susc Isolate Pt OrdQn     ACTIVE Tildipirosin [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100060-3         Both       0 Tildipirosin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Bovine Respiratory Disease; BRD; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Zuprevo 2.72 2.72                       0  
100061-1 Tosufloxacin Susc Isolate Pt OrdQn     ACTIVE Tosufloxacin [Susceptibility]   ADD DefinitionDescription                   ABXBACT   100061-1         Both       0 Tosufloxacin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Ozex; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.72 2.72                       0  
100062-9 Standard Dermatology Outcome Measures panel - ^Patient Pt - SDOM   ACTIVE Standard Dermatology Outcome Measures panel   ADD DefinitionDescription         Copyright Ã?© 2016 The Regents of the University of California and Emory University. Used with permission.         PANEL.CLIN   100062-9   SDOM     Order       0 SDOM panel       N   CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; SDOM panel 2.72 2.72   Panel     Copyright Ã?© 2016 The Regents of the University of California and Emory University. Used with permission.             0  
100063-7 Primary skin concern Find ^Patient Pt Nom     ACTIVE Primary skin concern   ADD DefinitionDescription                   CLIN   100063-7         Observation       0 Primary skin concern       N   CLIN; Finding; Findings; Integument; Nominal; Point in time; Random 2.72 2.72                       0  
101,632 results found